Last update 20 Mar 2025

Tranilast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
N-(3,4-Dimethoxycinnamoyl)anthranilic acid, Tranilast (JP17/USAN/INN)
+ [9]
Target
Action
inhibitors
Mechanism
TGF-β inhibitors(Transforming growth factor beta inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Japan (15 Jun 1982),
RegulationOrphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC18H17NO5
InChIKeyNZHGWWWHIYHZNX-UHFFFAOYSA-N
CAS Registry53902-12-8

External Link

KEGGWikiATCDrug Bank
D02027Tranilast

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
China
28 Feb 2011
Dermatitis, Atopic
China
28 Feb 2011
Conjunctivitis, Allergic
Japan
29 Sep 1995
Conjunctivitis, Allergic
Japan
29 Sep 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PterygiumPhase 3
Brazil
01 Jan 2015
Rheumatoid ArthritisDiscovery
United Kingdom
01 Mar 2009
Rheumatoid ArthritisDiscovery
Argentina
01 Mar 2009
Rheumatoid ArthritisDiscovery
United States
01 Mar 2009
Rheumatoid ArthritisDiscovery
Serbia
01 Mar 2009
Rheumatoid ArthritisDiscovery
Mexico
01 Mar 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
(Irradiation Group)
(cdbmvncsob) = eauonmjhsd cqcutlhdcj (vbuyeugved )
-
15 Oct 2023
Tranilast Pre-treated Irradiation Group
(cdbmvncsob) = ypvdufpdtj cqcutlhdcj (vbuyeugved )
Not Applicable
Dermatomyositis
TIF-g | NXP-2
111
(Antibodies to TIF-g)
monwtcioqc(wyhgxukswl) = zearzkhhpn wwyfdtuybn (rkzzzraveq )
-
09 Nov 2012
Not Applicable
-
unvrphqkdd(icgnqotxax) = faljzzdccl vrsohqjzbh (wiziqxrfak )
-
01 Nov 2006
Vehicle
unvrphqkdd(icgnqotxax) = pjzsbgloga vrsohqjzbh (wiziqxrfak )
Not Applicable
-
4
osusawohex(tvxglahsit) = vlddowabrc utfwhmsjjp (gkzpgegczl )
Positive
01 May 2006
Phase 3
-
32
gvppmdaxsu(cbrkrqypsx) = bkqjtgywjn dswclwbwfd (krhdvvwnjr )
-
01 Mar 2004
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free